Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$10.7 - $17.84 $2.04 Million - $3.4 Million
-190,381 Reduced 61.54%
118,971 $1.91 Million
Q3 2022

Nov 14, 2022

BUY
$12.84 - $24.13 $3.11 Million - $5.84 Million
242,213 Added 360.76%
309,352 $4.11 Million
Q2 2022

Aug 15, 2022

SELL
$16.75 - $22.54 $1.48 Million - $1.99 Million
-88,476 Reduced 56.86%
67,139 $1.44 Million
Q1 2022

May 09, 2022

BUY
$17.89 - $28.73 $2.78 Million - $4.47 Million
155,615 New
155,615 $3.34 Million
Q4 2021

Feb 01, 2022

SELL
$26.1 - $45.21 $744,476 - $1.29 Million
-28,524 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$24.46 - $38.41 $697,697 - $1.1 Million
28,524 New
28,524 $944,000
Q2 2021

Aug 13, 2021

SELL
$24.79 - $33.31 $618,089 - $830,518
-24,933 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$25.58 - $39.0 $307,471 - $468,780
12,020 Added 93.08%
24,933 $681,000
Q4 2020

Feb 16, 2021

BUY
$33.59 - $40.18 $433,747 - $518,844
12,913 New
12,913 $435,000

Others Institutions Holding CERT

About Certara, Inc.


  • Ticker CERT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 159,899,008
  • Market Cap $2.08B
  • Description
  • Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company al...
More about CERT
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.